R. Cereda
Impact in
-
- Neuropeptides and Animal Physiology
Papers in
-
- Fibroblast Growth Factor Research 4
- Kruppel-like factors research 3
-
- Neuropeptides and Animal Physiology 5
- Co-authors
- Laura Revel (9 shared papers)I Setnikar (8 shared papers)Francesco Makovec (8 shared papers)Massimo Bani (6 shared papers)Renan Campos Chisté (6 shared papers)Lucio C. Rovati (4 shared papers)Filippo de Braud (4 shared papers)Angelo Delmonte (4 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (1 paper)Peptides (1 paper)European Journal of Cancer (1 paper)Revista Neurociências (1 paper)
In The Last Decade
R. Cereda
14 papers receiving 442 citations
Peers
Comparison fields: 5 of 75
- Cellular and Molecular Neuroscience 148
- Gastroenterology 29
- Cancer Research 59
- Rheumatology 56
- Oncology 101
Countries citing papers authored by R. Cereda
This map shows the geographic impact of R. Cereda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Cereda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Cereda more than expected).
Fields of papers citing papers by R. Cereda
This network shows the impact of papers produced by R. Cereda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Cereda. The network helps show where R. Cereda may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Cereda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 147 | |
| 2 | Antireactive properties of glucosamine sulfate. | 1991 | 74 |
| 3 | Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. | 1987 | 58 |
| 4 | Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist. | 1987 | 58 |
| 5 | 1986 | 31 | |
| 6 | Anticholecystokinin activities of loxiglumide. | 1987 | 31 |
| 7 | 2012 | 19 | |
| 8 | 1987 | 17 | |
| 9 | 2011 | 13 | |
| 10 | Loxiglumide protects against experimental pancreatitis. | 1987 | 12 |
| 11 | Pharmacological characterisation of the smooth muscle antispasmodic agent tiropramide. | 1989 | 4 |
| 12 | Antispasmodic activity of tiropramide. | 1989 | 3 |
| 13 | 2014 | 2 | |
| 14 | 2012 | 1 | |
| 15 | 2019 | 0 |
About R. Cereda
R. Cereda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Surgery, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 15 papers that have together received 470 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (5 papers), Fibroblast Growth Factor Research (4 papers), Kruppel-like factors research (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Pancreatitis Pathology and Treatment (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Soft tissue tumor case studies (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (148 citations), Gastroenterology (29 citations), Cancer Research (59 citations), Rheumatology (56 citations) and Oncology (101 citations). R. Cereda has collaborated with scholars based in Italy, Spain and France. Frequent co-authors include Laura Revel, I Setnikar, Francesco Makovec, Massimo Bani, Renan Campos Chisté, Lucio C. Rovati, Filippo de Braud, Angelo Delmonte, Rastilav Bahleda and Fabrice André. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Peptides, European Journal of Cancer and Revista Neurociências.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.